26
May
Lincoln Pharmaceuticals Limited has reported net profit of Rs. 11.85-crore in Q4FY21 as against net profit of Rs. 9.23-crore in the corresponding period last year, growth of 28.33%. Net revenue from operations in Q4FY21 was reported at Rs. 77.54-crore, higher by 3.03% over previous fiscal’s same period net revenue from operations of Rs. 75.26-crore. Company reported EBITDA of Rs. 16.74-crore in Q4FY21, rise of 28.25% as compared to Rs. 13.05-crore in the corresponding period last year. EPS for Q4FY21 was at Rs. 5.92 per share as compared to Rs. 4.62 in the corresponding period last year. Company has recommended dividend…